224 related articles for article (PubMed ID: 21105841)
1. Clinicopathologic findings following intra-articular injection of autologous and allogeneic placentally derived equine mesenchymal stem cells in horses.
Carrade DD; Owens SD; Galuppo LD; Vidal MA; Ferraro GL; Librach F; Buerchler S; Friedman MS; Walker NJ; Borjesson DL
Cytotherapy; 2011 Apr; 13(4):419-30. PubMed ID: 21105841
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory response to the administration of mesenchymal stem cells in an equine experimental model: effect of autologous, and single and repeat doses of pooled allogeneic cells in healthy joints.
Ardanaz N; Vázquez FJ; Romero A; Remacha AR; Barrachina L; Sanz A; Ranera B; Vitoria A; Albareda J; Prades M; Zaragoza P; Martín-Burriel I; Rodellar C
BMC Vet Res; 2016 Mar; 12():65. PubMed ID: 27029614
[TBL] [Abstract][Full Text] [Related]
3. Equine allogeneic umbilical cord blood derived mesenchymal stromal cells reduce synovial fluid nucleated cell count and induce mild self-limiting inflammation when evaluated in an lipopolysaccharide induced synovitis model.
Williams LB; Koenig JB; Black B; Gibson TW; Sharif S; Koch TG
Equine Vet J; 2016 Sep; 48(5):619-25. PubMed ID: 26114736
[TBL] [Abstract][Full Text] [Related]
4. Investigation of the immune response to autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
Vet Immunol Immunopathol; 2013 Nov; 156(1-2):99-106. PubMed ID: 24094688
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory effects of autologous, genetically modified autologous, allogeneic, and xenogeneic mesenchymal stem cells after intra-articular injection in horses.
Pigott JH; Ishihara A; Wellman ML; Russell DS; Bertone AL
Vet Comp Orthop Traumatol; 2013; 26(6):453-60. PubMed ID: 24080668
[TBL] [Abstract][Full Text] [Related]
6. Repeated intra-articular injection of allogeneic mesenchymal stem cells causes an adverse response compared to autologous cells in the equine model.
Joswig AJ; Mitchell A; Cummings KJ; Levine GJ; Gregory CA; Smith R; Watts AE
Stem Cell Res Ther; 2017 Feb; 8(1):42. PubMed ID: 28241885
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic vs. autologous intra-articular mesenchymal stem cell injection within normal horses: Clinical and cytological comparisons suggest safety.
Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
Equine Vet J; 2020 Jan; 52(1):144-151. PubMed ID: 31120574
[TBL] [Abstract][Full Text] [Related]
8. Single and repeated intra-articular injections in the tarsocrural joint with allogeneic and autologous equine bone marrow-derived mesenchymal stem cells are safe, but did not reduce acute inflammation in an experimental interleukin-1β model of synovitis.
Colbath AC; Dow SW; Hopkins LS; Phillips JN; McIlwraith CW; Goodrich LR
Equine Vet J; 2020 Jul; 52(4):601-612. PubMed ID: 31821594
[TBL] [Abstract][Full Text] [Related]
9. Intradermal injections of equine allogeneic umbilical cord-derived mesenchymal stem cells are well tolerated and do not elicit immediate or delayed hypersensitivity reactions.
Carrade DD; Affolter VK; Outerbridge CA; Watson JL; Galuppo LD; Buerchler S; Kumar V; Walker NJ; Borjesson DL
Cytotherapy; 2011 Nov; 13(10):1180-92. PubMed ID: 21899391
[TBL] [Abstract][Full Text] [Related]
10. Production of Cytotoxic Antibodies After Intra-Articular Injection of Allogeneic Synovial Membrane Mesenchymal Stem Cells With and Without LPS Administration.
Rosa GDS; Krieck AMT; Padula ET; Stievani FC; Rossi MC; Pfeifer JPH; Basso RM; Braz AMM; Golim MA; Alves ALG
Front Immunol; 2022; 13():871216. PubMed ID: 35572507
[TBL] [Abstract][Full Text] [Related]
11. Equine allogeneic bone marrow-derived mesenchymal stromal cells elicit antibody responses in vivo.
Pezzanite LM; Fortier LA; Antczak DF; Cassano JM; Brosnahan MM; Miller D; Schnabel LV
Stem Cell Res Ther; 2015 Apr; 6(1):54. PubMed ID: 25889095
[TBL] [Abstract][Full Text] [Related]
12. Equine allogeneic chondrogenic induced mesenchymal stem cells: A GCP target animal safety and biodistribution study.
Broeckx SY; Spaas JH; Chiers K; Duchateau L; Van Hecke L; Van Brantegem L; Dumoulin M; Martens AM; Pille F
Res Vet Sci; 2018 Apr; 117():246-254. PubMed ID: 29329028
[TBL] [Abstract][Full Text] [Related]
13. In vitro MSC function is related to clinical reaction in vivo.
Rowland AL; Xu JJ; Joswig AJ; Gregory CA; Antczak DF; Cummings KJ; Watts AE
Stem Cell Res Ther; 2018 Nov; 9(1):295. PubMed ID: 30409211
[TBL] [Abstract][Full Text] [Related]
14. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses.
Kol A; Wood JA; Carrade Holt DD; Gillette JA; Bohannon-Worsley LK; Puchalski SM; Walker NJ; Clark KC; Watson JL; Borjesson DL
Stem Cell Res Ther; 2015 Apr; 6(1):73. PubMed ID: 25888916
[TBL] [Abstract][Full Text] [Related]
15. Cross-matching of allogeneic mesenchymal stromal cells eliminates recipient immune targeting.
Rowland AL; Miller D; Berglund A; Schnabel LV; Levine GJ; Antczak DF; Watts AE
Stem Cells Transl Med; 2021 May; 10(5):694-710. PubMed ID: 33369287
[TBL] [Abstract][Full Text] [Related]
16. Assessment of effectiveness and safety of repeat administration of proinflammatory primed allogeneic mesenchymal stem cells in an equine model of chemically induced osteoarthritis.
Barrachina L; Remacha AR; Romero A; Vitoria A; Albareda J; Prades M; Roca M; Zaragoza P; Vázquez FJ; Rodellar C
BMC Vet Res; 2018 Aug; 14(1):241. PubMed ID: 30119668
[TBL] [Abstract][Full Text] [Related]
17. Treatment Effects of Intra-Articular Allogenic Mesenchymal Stem Cell Secretome in an Equine Model of Joint Inflammation.
Kearney CM; Khatab S; van Buul GM; Plomp SGM; Korthagen NM; Labberté MC; Goodrich LR; Kisiday JD; Van Weeren PR; van Osch GJVM; Brama PAJ
Front Vet Sci; 2022; 9():907616. PubMed ID: 35812845
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the inflammatory response to two intra-articular hyaluronic acid formulations in normal equine joints.
Johnston GCA; Wood KA; Jackson KV; Perkins NR; Zedler ST
J Vet Pharmacol Ther; 2020 Jan; 43(1):38-49. PubMed ID: 31660636
[TBL] [Abstract][Full Text] [Related]
19. Comparison of efficacy and safety of single versus repeated intra-articular injection of allogeneic neonatal mesenchymal stem cells for treatment of osteoarthritis of the metacarpophalangeal/metatarsophalangeal joint in horses: A clinical pilot study.
Magri C; Schramme M; Febre M; Cauvin E; Labadie F; Saulnier N; François I; Lechartier A; Aebischer D; Moncelet AS; Maddens S
PLoS One; 2019; 14(8):e0221317. PubMed ID: 31465445
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Allogeneic Bone-Marrow-Derived and Umbilical Cord Blood-Derived Mesenchymal Stem Cells to Prevent the Development of Osteoarthritis in An Equine Model.
Bertoni L; Jacquet-Guibon S; Branly T; Desancé M; Legendre F; Melin M; Rivory P; Hartmann DJ; Schmutz A; Denoix JM; Demoor M; Audigié F; Galéra P
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33801461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
